GBS Inc. to Present Second Quarter 2022 Financial Results and Recent Corporate Update on February 10
GBS Inc. will release its financial results for the second quarter ending December 31, 2021, after NASDAQ market close on February 10, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GBS Inc. will release its financial results for the second quarter ending December 31, 2021, after NASDAQ market close on February 10, 2022. A conference call is scheduled for 4:30 p.m. ET on the same day, where management will discuss the results. Interested parties can join the call via toll-free numbers or through a webcast available on the company’s website. GBS is focused on developing non-invasive diagnostic tests for diabetes management.
Details
News Market Reaction – GBS
The recorded move for GBS in the trading session of this news was +5.49%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company to Host Conference Call & Webcast at 4:30 p.m. ET
NEW YORK, Feb. 07, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced that it will release its financial results for the second quarter ended December 31, 2021, shortly after the NASDAQ market close on Thursday, February 10. Management will then host a conference call and webcast at 4:30 p.m. ET.
| Title: | GBS, Inc. Second Quarter 2022 Financial Results Conference Call & Webcast |
| Date: | Thursday, February 10, 2022 |
| Time: | 4:30 p.m. ET |
| Conference Call Details: | Toll-Free: 877-407-3982 International: 201-493-6780 Conference ID: 13726819 |
| The conference call will be webcast live from the Company’s website and will be available via the following links: | |
| Webcast: | Webcast Registration Link https://themediaframe.com/mediaframe/webcast.html?webcastid=AjR9Yqzr https://investors.gbs.inc/news-and-events/investor-calendar |
The webcast should be accessed 15 minutes prior to the conference call start time.
A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company’s website.
About GBS Inc.
GBS Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. With the world-first Biosensor Platform, GBS Inc. is developing and launching diagnostic tests urgently needed to help people living with diabetes. For more information, please visit GBS.inc.
Investor Contact:
Tim McCarthy – Managing Director
LifeSci Advisors, LLC
Tim@LifeSciAdvisors.com
Company Contact:
Spiro Sakiris – Chief Financial Officer
GBS, Inc.
Investor.Relations@gbs.inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.